Charles River Lab (CRL) - Forward P/S Multiple

Brandmark of Charles River (CRL)

Charles River Laboratories (CRL) revenues depend on venture capital infusions into biotech startups, which creates moderate volatility in cash flows. An analysis of the future EV/Revenue multiple on the GURU.Markets chart demonstrates valuation dynamics, where the value 0.30 shows the current figure. The business foundation is based on unique laboratory models and rigorous standards, guaranteeing customer loyalty and global leadership in the preclinical sector.

CRL Charles River: Forward Price to Sales in the range 07/04/2022 - 11/13/2026

CRL (Charles River Corp): analytical breakdowns and indicator data

- current price and projected stock value:
Stock Price Charles River|CRL - Fair Value Consensus
- market capitalization indicators:
Market Capitalization Charles River Corp|CRL - Enterprise Value
- issuer book value statistics:
Net Assets per Single Share Charles River|CRL - Accounting Value of Company|Market Value to Book Value Ratio criver.com|CRL - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Charles River Laboratories|CRL - Long-Term Liabilities to Capital|Short-Term Debt to Equity Charles River Laboratories|CRL - Company Total Debt Obligations|Debt to Book Value Charles River Corp|CRL - Company Long-Term Loans and Borrowings|Company Short-Term Debt Charles River|Quick Ratio criver.com
- business earnings and investment ratios data:
CRL - Net Financial Result|Future Profit Charles River Laboratories|CRL - Price to Earnings Ratio|Forward P/E Multiple Charles River Lab|CRL - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Charles River Corp|CRL - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months Charles River|CRL - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months criver.com|CRL - Earnings per share growth in current year|Earnings growth forecast for next year Charles River Laboratories
- company sales and revenue statistics:
CRL - Revenue and Sales Volume|Projected Sales Volume Charles River|CRL - Price-to-Revenue Ratio|Price-to-Projected Revenue Ratio Charles River Corp
Comprehensive company analysis:Charles River (CRL)
Product sample of Charles River Laboratories

Charles River Laboratories (CRL) leadership in the preclinical research sector and regulatory barriers ensure business resilience, making the forward EV/Revenue multiple a key indicator of market confidence. This chart reflects the ratio of the company's current valuation to expected sales, allowing investors to quickly assess whether the asset is overbought or possesses growth potential based on future cash flow dynamics.

Key competitors

Forward P/S Multiple IQV (IQVIA)|Forward Price to Sales LH|Medpace Inc. - Forward P/S Multiple|ICLR - Forward P/S Multiple|Evotec SE (EVO) - Price-to-Projected Revenue Ratio|fortrea.com - Forward Price to Sales|Price-to-Projected Revenue Ratio Lifecore Biomedical Inc.|Price-to-Projected Revenue Ratio OABI|Forward P/S Multiple NOTV|CDMO - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Catalent, Inc. CTLT|Market Cap to Expected Sales Ratio nighthawkbio.com (SCPX)